México Mercado de Soluciones Intravenosas Tamaño, Participación, Tendencias y Pronóstico por Tipo, Nutrientes, y Región, 2026-2034

Overview of the Intravenous Solutions Market in Mexico:

The intravenous solutions market in Mexico reached USD 244.8 million in 2025. Looking ahead, IMARC Group expects the market to reach USD 366.1 million by 2034 , exhibiting a compound annual growth rate (CAGR) of 4.44% during 2026-2034 .  The market is driven by factors such as the increasing prevalence of chronic diseases, the aging population, advancements in intravenous therapy technology, the growth of healthcare infrastructure, government initiatives to improve access to healthcare, and the rise of home healthcare services that require effective and safe intravenous fluid administration.

Trends in the intravenous solutions market in Mexico:

Increasing prevalence of chronic diseases and medical conditions

The increasing incidence of chronic diseases such as diabetes, hypertension, and cancer in Mexico has contributed to the expansion of the intravenous (IV) solutions market. Chronic diseases tend to last for years, and patients with these conditions often require IV solutions for hydration and the administration of nutrients and medications. For example, diabetic patients may need IV solutions to maintain electrolyte balance and regulate glucose levels, while cancer patients undergoing chemotherapy require IV fluids to combat dehydration and manage side effects such as nausea. Furthermore, the growing geriatric population in Mexico, which is also more prone to chronic diseases, is further driving the demand for IV solutions. This demographic shift translates into more hospital admissions and longer treatment periods, necessitating the regular use of IV solutions. The increasing prevalence of chronic diseases creates a demand for a constant supply of intravenous fluids, driving the market as hospitals and healthcare providers need to maintain a sufficient inventory of different intravenous solutions for the treatment of their patients.

Technological advances in intravenous therapy delivery systems

Advances in medical technology have been the primary drivers of the Mexican intravenous solutions market's development. Improved and more user-friendly intravenous administration systems, such as infusion pumps and closed-circuit delivery systems, have enabled more precise and controlled administration of intravenous solutions. These new delivery systems mitigate the potential for human error, improve patient safety, and enhance overall treatment outcomes. For example, current infusion pumps are equipped with features such as rate control, monitoring, and alarms in case of malfunction, making intravenous therapy significantly more effective. As Mexican healthcare institutions adopt these technological advancements, the demand for compatible intravenous solutions increases. Clinics and hospitals are investing in advanced infusion devices to improve patient care, which translates to greater IV fluid usage. Furthermore, these technological advancements are targeting more therapeutic areas, such as pediatrics, oncology, and intensive care units, where precise intravenous administration is essential. The transition to digital and automated intravenous administration systems has driven the latest increase in demand for intravenous solutions in the Mexican healthcare sector.

Segmentation of the intravenous solutions market in Mexico:

The IMARC Group offers an analysis of key trends in each market segment, along with regional/country-level forecasts for 2026-2034. Our report has categorized the market based on type and nutrients.

Insights Type:

• Partial parenteral nutrition
• Total parenteral nutrition

The report offers a detailed breakdown and analysis of the market based on type. It includes partial parenteral nutrition and total parenteral nutrition.

Nutrients Insights:

• Carbohydrates 
• Salts and electrolytes 
• Minerals 
• Vitamins 
• Amino acids 

The report also provides a detailed breakdown and analysis of the market based on nutrients. This includes carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids.

Regional perspectives:

• Northern Mexico 
• Central Mexico 
• Southern Mexico 
• Others

The report also provided a comprehensive analysis of key regional markets, including northern Mexico, central Mexico, southern Mexico, and others.

Competitive landscape:

The market research report also provides a comprehensive analysis of the competitive landscape. This includes competitive analysis such as market structure, key player positioning, leading winning strategies, a competitive dashboard, and a company assessment quadrant. Detailed profiles of the top companies are also provided.

News from the Intravenous Solutions Market in Mexico:

• December 2023: The Mexican government inaugurated a centralized, 40,000-square-meter "superpharmacy" in Huehuetoca, Mexico, with the goal of addressing the nationwide drug shortage. This facility is designed to supply hospitals with essential medications, including intravenous (IV) solutions, within 24 to 48 hours through the armed forces or the state-owned pharmaceutical company Birmex.
• July 2023: General Atlantic invested up to $160 million USD in MAC Hospitals to expand access to affordable healthcare throughout Mexico. This partnership enables MAC Hospitals to develop new facilities, upgrade its technology infrastructure, and enhance its service offerings. The expansion of healthcare services, including intravenous therapies, is driving demand for medical supplies and equipment, positively impacting the intravenous solutions market in Mexico.

Coverage of the report on the intravenous solutions market in Mexico:

Key questions answered in this report:

• How has the Mexican market for intravenous solutions performed so far, and how will it perform in the coming years?
• What is the distribution of the Mexican market for intravenous solutions by type?
• What is the distribution of the Mexican market for intravenous nutrient solutions?
• What is the distribution of the Mexican market for intravenous solutions by region?
• What are the different stages of the value chain in the intravenous solutions market in Mexico?
• What are the main driving factors and challenges of the intravenous solutions market in Mexico?
• What is the structure of the Mexican market for intravenous solutions and who are its main players?
• What is the level of competition in the Mexican market for intravenous solutions?

Main benefits for stakeholders:

• IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and market dynamics for intravenous solutions in Mexico from 2020 to 2034.
• The research report provides the latest information on market drivers, challenges, and opportunities in the Mexican intravenous solutions market.
• Porter's Five Forces analysis helps stakeholders assess the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders analyze the level of competition in the intravenous solutions sector in Mexico and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of the major market players.